ConductScience.org, home

Trial · NCT04404361

Results by group76

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Percentage of Participants With Progression to IMV and/or ECMO or DeathPacritinib and SOC26Participants
Percentage of Participants With Progression to IMV and/or ECMO or DeathPlacebo and SOC25Participants
The Number of Ventilator-Free DaysPacritinib and SOC22.1Standard Deviation 10.2days
The Number of Ventilator-Free DaysPlacebo and SOC22.6Standard Deviation 9.35days
The Mortality Rate at Day 28Pacritinib and SOC10.195% Confidence Interval 5.0 to 17.8% of patients with outcome of death /D28
The Mortality Rate at Day 28Placebo and SOC7.995% Confidence Interval 3.5 to 15.0% of patients with outcome of death /D28
The Mortality Rate at Day 15Pacritinib and SOC5.195% Confidence Interval 1.7 to 11.4% of patients with outcome of death /D15
The Mortality Rate at Day 15Placebo and SOC4.095% Confidence Interval 1.1 to 9.8% of patients with outcome of death /D15
The Time to Improvement by at Least 2 Points Relative to Baseline on the 7-point Ordinal Scale of Clinical StatusPacritinib and SOC9.095% Confidence Interval 8.0 to 10.0days
The Time to Improvement by at Least 2 Points Relative to Baseline on the 7-point Ordinal Scale of Clinical StatusPlacebo and SOC9.095% Confidence Interval 7.0 to 11.0days
The Clinical Status as Assessed by the 7-point Ordinal Scale of Clinical Status at Days 8, 15, 22, and 28Pacritinib and SOCDay 8 : Clinical status 115participants
The Clinical Status as Assessed by the 7-point Ordinal Scale of Clinical Status at Days 8, 15, 22, and 28Placebo and SOCDay 8 : Clinical status 111participants
The Clinical Status as Assessed by the 7-point Ordinal Scale of Clinical Status at Days 8, 15, 22, and 28Pacritinib and SOCDay 8 : Clinical status 223participants
The Clinical Status as Assessed by the 7-point Ordinal Scale of Clinical Status at Days 8, 15, 22, and 28Placebo and SOCDay 8 : Clinical status 237participants
The Clinical Status as Assessed by the 7-point Ordinal Scale of Clinical Status at Days 8, 15, 22, and 28Pacritinib and SOCDay 8 : Clinical status 35participants
The Clinical Status as Assessed by the 7-point Ordinal Scale of Clinical Status at Days 8, 15, 22, and 28Placebo and SOCDay 8 : Clinical status 33participants
The Clinical Status as Assessed by the 7-point Ordinal Scale of Clinical Status at Days 8, 15, 22, and 28Pacritinib and SOCDay 8 : Clinical status 420participants
The Clinical Status as Assessed by the 7-point Ordinal Scale of Clinical Status at Days 8, 15, 22, and 28Placebo and SOCDay 8 : Clinical status 411participants
The Clinical Status as Assessed by the 7-point Ordinal Scale of Clinical Status at Days 8, 15, 22, and 28Pacritinib and SOCDay 8 : Clinical status 515participants
The Clinical Status as Assessed by the 7-point Ordinal Scale of Clinical Status at Days 8, 15, 22, and 28Placebo and SOCDay 8 : Clinical status 520participants

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04404361/results